ZLNA fundamentals
Key facts
Market capitalization—
Founded—
CEO—
Website—
About
Zelluna ASA is a biotechnology company focused on developing innovative and cost-efficient therapies for advanced solid cancers. It develops “off-the-shelf” TCR-guided NK cell therapies (TCR-NK) to treat solid cancers, offering broad cancer detection and scalable treatment. The company is headquartered in Oslo, Norway.
Valuation
Fundamental metrics to determine fair value of the stock
Growth and Profitability
Company’s recent performance and margins
Dividends
Dividend yield, history and sustainability
ZLNA does not pay dividends
The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future
Financial health
Financial position and solvency of the company